Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Accenture
Federal Trade Commission
Harvard Business School
Queensland Health
AstraZeneca
Farmers Insurance
Mallinckrodt
Cipla

Generated: October 19, 2017

DrugPatentWatch Database Preview

PERGOLIDE MESYLATE Drug Profile

« Back to Dashboard

Which patents cover Pergolide Mesylate, and when can generic versions of Pergolide Mesylate launch?

Pergolide Mesylate is a drug marketed by Par Pharm and Ivax Sub Teva Pharms and is included in two NDAs.

The generic ingredient in PERGOLIDE MESYLATE is pergolide mesylate. There are four drug master file entries for this compound. Additional details are available on the pergolide mesylate profile page.

Summary for Tradename: PERGOLIDE MESYLATE

US Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list30
Clinical Trials: see list529
Patent Applications: see list1,308
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PERGOLIDE MESYLATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
PERGOLIDE MESYLATE
pergolide mesylate
TABLET;ORAL076061-001Nov 27, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
PERGOLIDE MESYLATE
pergolide mesylate
TABLET;ORAL076094-001Sep 4, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
PERGOLIDE MESYLATE
pergolide mesylate
TABLET;ORAL076061-002Nov 27, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
PERGOLIDE MESYLATE
pergolide mesylate
TABLET;ORAL076061-003Nov 27, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
PERGOLIDE MESYLATE
pergolide mesylate
TABLET;ORAL076094-003Sep 4, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
PERGOLIDE MESYLATE
pergolide mesylate
TABLET;ORAL076094-002Sep 4, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chinese Patent Office
McKinsey
Farmers Insurance
Cantor Fitzgerald
Accenture
AstraZeneca
Chubb
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot